Sevelamer Hydrochloride in Peritoneal Dialysis Patients

Sevelamer Hydrochloride in Peritoneal Dialysis Patients

Sponsor and Collaborators

The University of Hong Kong

Contact
Contact: Angela YM Wang, MD, FRCP
852-28554111 ext 4949
aymwang@hku.hk

Principal Investigator
Angela YM Wang, MD, FRCP Queen Mary Hospital, University of Hong Kong

ClinicalTrials.gov Identifier

NCT00745589
close

Next Article in Hyperphosphatemia Clinical Trials

More in Hyperphosphatemia Clinical Trials

Dose-finding Study of MCI-196

A look at the following clinical trial: Dose-finding Study of MCI-196.

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With ...

A look at the following clinical trial: A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

A look at the following clinical trial: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.